ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vogelmeier, C
Right arrow Articles by Buhl, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vogelmeier, C
Right arrow Articles by Buhl, R
Eur Respir J 1997; 10: 2114-2119
Copyright © ERS Journals Ltd 1997

Original Articles

Comparative loss of activity of recombinant secretory leukoprotease inhibitor and alpha 1-protease inhibitor caused by different forms of oxidative stress

C Vogelmeier, T Biedermann, K Maier, G Mazur, J Behr, F Krombach, and R Buhl

Secretory leukoprotease inhibitor (SLPI) and alpha 1-protease inhibitor (alpha 1-PI) are powerful antiproteases currently under investigation for their potential to protect the lung from neutrophil elastase (NE). The aim of this study was to determine whether the recombinant form of SLPI (rSLPI) and alpha 1-PI show different grades of loss of inhibitory activity when exposed to reactive oxygen metabolites. We incubated rSLPI and alpha 1-PI with N-chlorosuccinimide (NCS), chloramines, activated polymorphonuclear leucocytes (PMNs) and activated alveolar macrophages (AMs). Under all conditions evaluated, both antiproteases were partially inactivated. The resulting anti-NE activity of rSLPI was not significantly different from that of alpha 1-PI after exposure to NCS (p > 0.5), chloramines (p > 0.6), activated PMNs (p > 0.07) and activated AMs (p > 0.9). In conclusion, recombinant secretory leukoprotease inhibitor and alpha 1-protease inhibitor lose antineutrophil elastase activity to a similar extent when exposed to conditions that may be present in inflammatory lung disorders.


This article has been cited by other articles:


Home page
 Toxicol SciHome page
I. Jaspers, J. M. Ciencewicki, W. Zhang, L. E. Brighton, J. L. Carson, M. A. Beck, and M. C. Madden
Diesel Exhaust Enhances Influenza Virus Infections in Respiratory Epithelial Cells
Toxicol. Sci., June 1, 2005; 85(2): 990 - 1002.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
M. Scuri, Y. Botvinnikova, I. T. Lauredo, and W. M. Abraham
Recombinant alpha 1-proteinase inhibitor blocks antigen- and mediator-induced airway responses in sheep
J Appl Physiol, December 1, 2002; 93(6): 1900 - 1906.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Huber-Lang, E. M. Younkin, J. V. Sarma, N. Riedemann, S. R. McGuire, K. T. Lu, R. Kunkel, J. G. Younger, F. S. Zetoune, and P. A. Ward
Generation of C5a by Phagocytic Cells
Am. J. Pathol., November 1, 2002; 161(5): 1849 - 1859.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
C. P. Rooney, C. Taggart, R. Coakley, N. G. McElvaney, and S. J. O'Neill
Anti-Proteinase 3 Antibody Activation of Neutrophils Can Be Inhibited by alpha 1-Antitrypsin
Am. J. Respir. Cell Mol. Biol., June 1, 2001; 24(6): 747 - 754.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the European Respiratory Society.